94 related articles for article (PubMed ID: 27823883)
1. Oligonucleotide transition state analogues of saporin L3.
Mason JM; Yuan H; Evans GB; Tyler PC; Du Q; Schramm VL
Eur J Med Chem; 2017 Feb; 127():793-809. PubMed ID: 27823883
[TBL] [Abstract][Full Text] [Related]
2. Transition State Structure of RNA Depurination by Saporin L3.
Yuan H; Stratton CF; Schramm VL
ACS Chem Biol; 2016 May; 11(5):1383-90. PubMed ID: 26886255
[TBL] [Abstract][Full Text] [Related]
3. Transition state analogues rescue ribosomes from saporin-L1 ribosome inactivating protein.
Sturm MB; Tyler PC; Evans GB; Schramm VL
Biochemistry; 2009 Oct; 48(41):9941-8. PubMed ID: 19764816
[TBL] [Abstract][Full Text] [Related]
4. Soapwort Saporin L3 Expression in Yeast, Mutagenesis, and RNA Substrate Specificity.
Yuan H; Du Q; Sturm MB; Schramm VL
Biochemistry; 2015 Jul; 54(29):4565-74. PubMed ID: 26091305
[TBL] [Abstract][Full Text] [Related]
5. Soapwort saponins trigger clathrin-mediated endocytosis of saporin, a type I ribosome-inactivating protein.
Weng A; Bachran C; Fuchs H; Melzig MF
Chem Biol Interact; 2008 Nov; 176(2-3):204-11. PubMed ID: 18775419
[TBL] [Abstract][Full Text] [Related]
6. Transition state analogues in structures of ricin and saporin ribosome-inactivating proteins.
Ho MC; Sturm MB; Almo SC; Schramm VL
Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20276-81. PubMed ID: 19920175
[TBL] [Abstract][Full Text] [Related]
7. Small structural differences of targeted anti-tumor toxins result in strong variation of protein expression.
Gilabert-Oriol R; Thakur M; Weise C; Dernedde J; von Mallinckrodt B; Fuchs H; Weng A
Protein Expr Purif; 2013 Sep; 91(1):54-60. PubMed ID: 23867360
[TBL] [Abstract][Full Text] [Related]
8. The thermal unfolding of the ribosome-inactivating protein saporin-S6 characterized by infrared spectroscopy.
Sánchez M; Scirè A; Tanfani F; Ausili A
Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1357-64. PubMed ID: 26096917
[TBL] [Abstract][Full Text] [Related]
9. Structure/function studies on two type 1 ribosome inactivating proteins: Bouganin and lychnin.
Fermani S; Tosi G; Farini V; Polito L; Falini G; Ripamonti A; Barbieri L; Chambery A; Bolognesi A
J Struct Biol; 2009 Nov; 168(2):278-87. PubMed ID: 19616098
[TBL] [Abstract][Full Text] [Related]
10. Ribosome inactivating protein saporin induces apoptosis through mitochondrial cascade, independent of translation inhibition.
Sikriwal D; Ghosh P; Batra JK
Int J Biochem Cell Biol; 2008; 40(12):2880-8. PubMed ID: 18611444
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of Anti-HIV Activity of Ribosome Inactivating Protein, Saporin.
Yadav SK; Batra JK
Protein Pept Lett; 2015; 22(6):497-503. PubMed ID: 25925771
[TBL] [Abstract][Full Text] [Related]
12. Endocytosis and intracellular localisation of type 1 ribosome-inactivating protein saporin-s6.
Bolognesi A; Polito L; Scicchitano V; Orrico C; Pasquinelli G; Musiani S; Santi S; Riccio M; Bortolotti M; Battelli MG
J Biol Regul Homeost Agents; 2012; 26(1):97-109. PubMed ID: 22475101
[TBL] [Abstract][Full Text] [Related]
13. Enzymatic specificity of three ribosome-inactivating proteins against fungal ribosomes, and correlation with antifungal activity.
Park SW; Stevens NM; Vivanco JM
Planta; 2002 Dec; 216(2):227-34. PubMed ID: 12447536
[TBL] [Abstract][Full Text] [Related]
14. Lipopolyamine treatment increases the efficacy of intoxication with saporin and an anticancer saporin conjugate.
Geden SE; Gardner RA; Fabbrini MS; Ohashi M; Phanstiel Iv O; Teter K
FEBS J; 2007 Sep; 274(18):4825-36. PubMed ID: 17714513
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of saporin toxicity against U937 cells by Gypsophila saponins.
Weng A; Melzig MF; Bachran C; Fuchs H
J Immunotoxicol; 2008 Jul; 5(3):287-92. PubMed ID: 18830889
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of saporin genes upon wounding, ABA treatment and leaf development.
Tartarini A; Pittaluga E; Marcozzi G; Testone G; Rodrigues-Pousada RA; Giannino D; Spanò L
Physiol Plant; 2010 Oct; 140(2):141-52. PubMed ID: 20536785
[TBL] [Abstract][Full Text] [Related]
17. Ribosome-inactivating proteins: current status and biomedical applications.
Puri M; Kaur I; Perugini MA; Gupta RC
Drug Discov Today; 2012 Jul; 17(13-14):774-83. PubMed ID: 22484096
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of four type-1 ribosome-inactivating proteins, with polynucleotide:adenosine glycosidase activity, from leaves of Phytolacca dioica L.
Di Maro A; Valbonesi P; Bolognesi A; Stirpe F; De Luca P; Siniscalco Gigliano G; Gaudio L; Delli Bovi P; Ferranti P; Malorni A; Parente A
Planta; 1999 Mar; 208(1):125-31. PubMed ID: 10213004
[TBL] [Abstract][Full Text] [Related]
19. Non-specific depurination activity of saporin-S6, a ribosome-inactivating protein, under acidic conditions.
Tang S; Hu RG; Liu WY; Ruan KC
Biol Chem; 2000 Aug; 381(8):769-72. PubMed ID: 11030435
[TBL] [Abstract][Full Text] [Related]
20. Saporin induces multiple death pathways in lymphoma cells with different intensity and timing as compared to ricin.
Polito L; Bortolotti M; Farini V; Battelli MG; Barbieri L; Bolognesi A
Int J Biochem Cell Biol; 2009 May; 41(5):1055-61. PubMed ID: 18935973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
